Lipodystrophy syndrome in HIV/aids patients

Authors

  • Marialida Mujica, Phd University Centrocidental Lisandro Alavarado, Venezuela.
  • Olga Herize Hospital Dr. Antonio María Casal
  • María Gonzalez Hospital Armando Velasquez Mago
  • Ramón Castillo Hospital Miguel Oraa

Keywords:

lipodystrophy syndrome, HIV/AIDS, Combined Antiretroviral Therapy

Abstract

To determine lipodystrophy syndrome (LDS) in HIV/AIDS patients attended in consultation the SIDA/ITS in the University Hospital “Dr. Miguel Oraá”, Guanare, Venezuela. A descriptive, ambipesctive study was conducted in a group of HVI/AIDS patients who received a combined anti-retroviral therapy. The information was collected from the clinical history and interviewing the patients. Eighty (80) patients were assessed; the mean age was 36.6 ± 12.0 years. The length of time using the combined anti-retroviral therapy varied (from less than 3 years to 15 years).

Author Biographies

  • Marialida Mujica, Phd, University Centrocidental Lisandro Alavarado, Venezuela.
    Lic in Bioanalysis. PhD in education. Professor and researcher in Dept. of Preventive Medicine,
    Deanship of Cs de la Salud, Centroccidental University Lisandro Alvatado Venezuela.
  • Olga Herize, Hospital Dr. Antonio María Casal

    Doctor, hospital Antonio Maria Casal, Acarigua, Venezuela.

  • María Gonzalez, Hospital Armando Velasquez Mago

    Doctor,Hospital Armando Velasquez Mago, Sarare edo Lara, Venezuela.

  • Ramón Castillo, Hospital Miguel Oraa

    Doctor, Hospital Miguel Oraa, Guanare, edo Portuguesa, Venezuela.

Downloads

Published

2018-08-05

Issue

Section

Artículos originales

How to Cite

Lipodystrophy syndrome in HIV/aids patients. (2018). Revista Venezolana de Salud Pública, 3(2), 23-28. https://revistas2.uclave.org/index.php/rvsp/article/view/1441